The agency has separately received adverse event reports that may relate to patients being prescribed compounded semaglutide or tirzepatide in doses beyond what is in the approved labeling more product per dose, more frequent dosing, or faster titration with reported symptoms including nausea, vomiting, diarrhoea, abdominal pain and constipation, some serious enough that patients sought medical attention
No wonder why you wake up unrefreshed
Kennedy Jr
Back to Journals Drug Design, Development and Therapy Volume 18 Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives Authors Gu X, Zhou H, Miao M, Hu D, Wang X, Zhou J, Teichmann AT, Yang Y, Wang C Received 20 February 2024 Accepted for publication 9 July 2024 Published 21 August 2024 Volume 2024:18 Pages 36673696 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Anastasios Lymperopoulos Xia Gu, 1, 2, * Hui Zhou, 1, * Mengyue Miao, 1 Daifeng Hu, 1 Xinyue Wang, 3 Jing Zhou, 4 Alexander Tobias Teichmann, 1 Youzhe Yang, 1, 5 Chunyan Wang 1 1 Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Peoples Republic of China
This enables patients to save time while receiving comprehensive care without having to leave home
